SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy

Hypophysitis is a well-recognized immune-related adverse event that occurs in approximately 16% of patients treated with immune checkpoint inhibitors (ICIs), particularly the anti-cytotoxic T-lymphocyte associated antigen (CTLA4) monoclonal antibody, ipilimumab. While the synthesis and secretion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapi, Sahityasri, Leiter, Amanda, Galsky, Matthew, Gallagher, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552875/
http://dx.doi.org/10.1210/js.2019-SUN-417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552875/
http://dx.doi.org/10.1210/js.2019-SUN-417

Ejemplares similares